[用β-吡啶甲醇治疗高胆固醇血症。II. 副作用及讨论] - Suppr | 超能文献

[Treatment of hypercholesterinemia with beta-pyridylcarbinol. II. Side effects and disscussion].

作者信息

Zöllner N, Gudenzi M

出版信息

Med Klin. 1966 Dec 23;61(51):2036-40.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Treatment of hypercholesterinemia with beta-pyridylcarbinol. II. Side effects and disscussion].[用β-吡啶甲醇治疗高胆固醇血症。II. 副作用及讨论]

Med Klin. 1966 Dec 23;61(51):2036-40.

2

[Lipid and carbohydrate metabolism in diabetics with hypercholesteremia during long-term treatment with beta-pyridylcarbinol].[β-吡啶甲醇长期治疗期间高胆固醇血症糖尿病患者的脂质和碳水化合物代谢]

Med Klin. 1970 Apr 3;65(14):668-76.

3

[Treatment of hypercholesteremia with beta-pyridylcarbinol. 3. Results of a 5-year supportive therapy].

Med Klin. 1971 Mar 26;66(13):474-84.

4

[Treatment of hypercholesteremia with beta-pyridylcarbinol. I. Biochemistry and clinical results].[用β-吡啶甲醇治疗高胆固醇血症。I. 生物化学与临床结果]

Med Klin. 1966 Dec 16;61(50):1996-2001.

5

[Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].

Med Klin. 1976 Apr 30;71(18):768-74.

6

[Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis].[脑动脉硬化症患者中吡硫醇与血管扩张剂联合应用的作用]

Rev Bras Med. 1972 Jan;29(1):38-41.

7

[Nicotinyl alcohol as a cholesterol-lowering agent].

Nord Med. 1969 May 29;81(22):698-700.

8

Clinical experience with a new coronary-active substance (BAY 1 1040).一种新型冠状活性物质（BAY 1 1040）的临床经验。

Arzneimittelforschung. 1972 Feb;22(2):380-9.

9

[Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].[氯苯丁酯或安妥明的抗血脂活性]

Minerva Med. 1969 Jan 20;60(6):174-80.

10

Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).氯苯氧异丁酸酯（安妥明）治疗的一些临床潜力（高脂血症——心绞痛——血液淤滞——糖尿病性神经病变）

Metabolism. 1968 May;17(5):457-73. doi: 10.1016/0026-0495(68)90068-1.